Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Ahn-Gook Pharmaceutical Co., Ltd. (001540:KRX), powered by AI.
Ahn-Gook Pharmaceutical Co., Ltd. is currently trading at ₩10,200. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Ahn-Gook Pharmaceutical Co., Ltd. on Alpha Lenz.
Ahn-Gook Pharmaceutical Co., Ltd.'s P/E ratio is 17.8.
“Ahn-Gook Pharmaceutical Co., Ltd. trades at a P/E of 17.8 (fair value) with modest ROE of 4.5%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.”
Ask for details →Ahn-Gook Pharmaceutical Co., Ltd. is a renowned company in the pharmaceutical industry, dedicated to the research, production, and distribution of a wide array of medicinal products. Since its inception, the company has been at the forefront of developing treatments that cater to both acute and chronic health conditions, enriching lives with its innovative healthcare solutions. The company's product line significantly impacts sectors such as cardiovascular, respiratory, and gastrointestinal medicine, offering life-saving drugs and long-term therapy options. With its strong emphasis on research and development, Ahn-Gook Pharmaceutical plays a crucial role in advancing medical science, fostering collaborations with academic institutions and healthcare organizations globally. Its commitment to quality assurance ensures safety and efficacy, bolstering trust among healthcare providers and patients alike. In the financial market, Ahn-Gook Pharmaceutical is a key player on the Korean Stock Exchange, representing the dynamic growth and resilience of South Korea's pharmaceutical sector. The company's steadfast dedication to health improvement and sustainable practices underscores its significant presence in the global healthcare landscape.
“Ahn-Gook Pharmaceutical Co., Ltd. trades at a P/E of 17.8 (fair value) with modest ROE of 4.5%. 3Y revenue CAGR of 14.3% highlights clear growth momentum.”
Ask for details →Ahn-Gook Pharmaceutical Co., Ltd. (ticker: 001540) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 402 employees. Market cap is $133.0B.
The current price is ₩10,200 with a P/E ratio of 17.78x and P/B of 0.8x.
ROE is 4.52% and operating margin is 3.20%. Annual revenue is $306.9B.